Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)
Journal article published in 2016 by
S. Caponnetto,
M. Mancini,
C. Manai,
V. Magri,
G. M. Iannantuono,
D. Pellegrino,
C. Mosillo,
G. Piesco,
G. Pomati,
S. Scagnoli 
,
F. Urbano,
S. Verkhovskaya,
G. Barchiesi,
S. Zancla,
E. Cortesi
,
F. Urbano,
S. Verkhovskaya,
G. Barchiesi,
S. Zancla,
E. Cortesi
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 